Haleon: If Staples Hold Up, The Stock Should Outperform (NYSE:HLN)
· seekingalpha.com
Haleon has underperformed since its 2022 spin from GSK, delivering just over 6% annualized returns, including dividends. Read why HLN stock is a Buy.
In its four-plus years as an independent company, Haleon ( HLN ) has underperformed. The consumer products giant, spun from GSK ( GSK ) in 2022, has returned a ...